<DOC>
	<DOCNO>NCT01022073</DOCNO>
	<brief_summary>Follow patient enrol CSP 468 , study deep brain stimulation treatment Parkinson 's disease</brief_summary>
	<brief_title>Follow Up Study Treatment Parkinson 's Disease With Deep Brain Stimulation</brief_title>
	<detailed_description>Parkinson 's disease ( PD ) , second prevalent neurodegenerative disease ( Alzheimer 's disease ) , affect million Americans common condition Veteran population . Although currently cure disease , many symptom disease effectively manage medication deep brain stimulation ( DBS ) . This study seek build upon original CSP # 468 protocol provide efficient long-term follow-up study . The objective study : determine whether motor benefit deep brain stimulation persist beyond two year follow-up patient Parkinson 's disease ; determine whether target stimulation ( GPi vs. STN ) affect durability long-term motor improvement ; define impact DBS long-term function quality life patient Parkinson 's disease ; identify clinical feature predict favorable unfavorable long-term outcome ; describe long-term performance DBS device , include device durability , device explanation rate , neurostimulator replacement frequency , change stimulation parameter achieve optimum symptom control .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Participant CSP # 468 Available willing followedup accord study protocol DBS device explanted permanently turn without anticipated resumption DBS therapy .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>Subthalamic Nucleus</keyword>
	<keyword>Globus Pallidus</keyword>
	<keyword>Parkinson Disease</keyword>
</DOC>